Skip to content

ESPED survey "Vitamin B12 deficiency in the first year of life"

ESPED survey "Vitamin B12 deficiency in the first year of life"

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00032822
Enrollment
50
Registered
2023-11-06
Start date
2021-01-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin B12 deficiency E53.8

Interventions

Group 1: Non-interventional, uncontrolled observational study (open) with anonymous data collection. Study procedure: With the help of the Erhebungseinheit für seltene pädiatrische Erkrankungen in De

Sponsors

Universitätsklinikum Heidelberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 12 Months

Inclusion criteria

Inclusion criteria: During the study period, newly diagnosed patients with clinically manifest infantile vitamin B12 deficiency.

Exclusion criteria

Exclusion criteria: - Patients already diagnosed before the start of the study. - Unconfirmed suspicion of a manifest infantile vitamin B12 deficiency. - Age > 12 months of life.

Design outcomes

Primary

MeasureTime frame
1. Incidence of clinically symptomatic, laboratory-confirmed vitamin B12 deficiency in the first year of life (vitamin B12 in serum/plasma: <160 pmol/l or <215 pg/ml and/or holo-transcobalamin in serum/plasma <35 pmol/l ) in Germany depending on the patient's region of residence/birth, comparing regions with and without newborn screening pilot projects for the identification of neonatal vitamin B12 deficiency. 2. Incidence of neonatal vitamin B12 deficiency identified in newborn screening. 3. Description of the age profile and clinical spectrum of symptomatic vitamin B12 deficiency at initial manifestation.

Secondary

MeasureTime frame
1. Description of the anamnestically recorded causes of the vitamin B12 deficiency (resorption disorder of the child, nutrition of the child until diagnosis, maternal nutritional habits, resorption disorders or medication intake). 2. Description of the diagnostic work-up (laboratory chemistry, neurological examination, cerebral imaging, EEG examination).

Countries

Germany

Contacts

Public ContactUlrike; Mütze;

Universität Heidelberg, Medizinische Fakultät Heidelberg, Zentrum für Kinder- und Jugendmedizin, Sektion für Neuropädiatrie und Stoffwechselmedizin;Erhebungseinheit für Seltene Pädiatrische Erkrankungen in Deutschland (ESPED), Institut für Medizinische Biometrie, Epidemiologie und Informatik (IMBEI), Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Ulrike.Muetze@med.uni-heidelberg.de;esped@uni-mainz.de+49 6221 56 37024;

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026